Literature DB >> 21563173

Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood.

Donald J Mabbott1, Eric Monsalves, Brenda J Spiegler, Ute Bartels, Laura Janzen, Sharon Guger, Normand Laperriere, Nicole Andrews, Eric Bouffet.   

Abstract

BACKGROUND: Central nervous system germ cell tumors (CNS GCT) are typically localized to midline structures of the brain, including the pineal and suprasellar/pituitary regions. Management of these tumors depends on underlying histology (germinoma or nongerminomatous germ cell tumor). Knowledge about neurocognitive outcome in these patients is limited. Longitudinal neurocognitive outcome in CNS GCT patients seen for neuropsychological evaluation at a single institution was explored.
METHODS: Thirty-five patients were seen for neurocognitive evaluation after diagnosis and treatment for a CNS GCT. Mean age at diagnosis was 11.66 years. Tumor location was suprasellar in 12 patients, pineal in 9, bifocal in 10, multifocal in 3, and thalamic in 1. Standardized cognitive tests of intelligence, receptive language, visual-motor ability, memory, and academic achievement were administered. Longitudinal and cross-sectional analyses were conducted.
RESULTS: Intelligence, academic functioning, and receptive vocabulary were not significantly compromised in most patients treated for CNS GCT. Working memory, information processing speed, and visual memory declined significantly over time in all patients. Patients with pineal tumors showed early and stable deficits, whereas patients with suprasellar and bifocal tumors showed more protracted declines from initial average functioning. Patients treated with ventricular versus craniospinal radiation displayed better outcome.
CONCLUSIONS: Although general cognitive abilities appeared stable and intact after treatment for most children with CNS GCT, a significant decline over time in working memory, processing speed, and visual memory was evident. Tumor location appeared to be important in understanding the trajectory of stability and decline in CNS GCT patients, as did radiation field.
Copyright © 2011 American Cancer Society.

Entities:  

Mesh:

Year:  2011        PMID: 21563173     DOI: 10.1002/cncr.26127

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  Processing speed in children treated for brain tumors: effects of radiation therapy and age.

Authors:  Lisa A Jacobson; E Mark Mahone; Keith O Yeates; M Douglas Ris
Journal:  Child Neuropsychol       Date:  2018-04-06       Impact factor: 2.500

2.  The potential utility of parent-reported attention screening in survivors of childhood cancer to identify those in need of comprehensive neuropsychological evaluation.

Authors:  Kristina K Hardy; Victoria W Willard; Alissa B Wigdor; Taryn M Allen; Melanie J Bonner
Journal:  Neurooncol Pract       Date:  2014-12-12

Review 3.  Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment).

Authors:  R B Raffa
Journal:  J Clin Pharm Ther       Date:  2013-05-08       Impact factor: 2.512

4.  Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.

Authors:  Amanda L Winter; Heather M Conklin; Vida L Tyc; Heather Stancel; Pamela S Hinds; Melissa M Hudson; Lisa S Kahalley
Journal:  J Clin Exp Neuropsychol       Date:  2014-08-15       Impact factor: 2.475

5.  Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study.

Authors:  Kristin J Redmond; E Mark Mahone; Stephanie Terezakis; Omar Ishaq; Eric Ford; Todd McNutt; Lawrence Kleinberg; Kenneth J Cohen; Moody Wharam; Alena Horska
Journal:  Neuro Oncol       Date:  2013-01-14       Impact factor: 12.300

6.  Prognostic factors that increase the risk for reduced white matter volumes and deficits in attention and learning for survivors of childhood cancers.

Authors:  Wilburn E Reddick; Delaram J Taghipour; John O Glass; Jason Ashford; Xiaoping Xiong; Shengjie Wu; Melanie Bonner; Raja B Khan; Heather M Conklin
Journal:  Pediatr Blood Cancer       Date:  2014-01-25       Impact factor: 3.167

7.  Computerized assessment of cognitive late effects among adolescent brain tumor survivors.

Authors:  Heather M Conklin; Jason M Ashford; Marcos Di Pinto; Christopher G Vaughan; Gerard A Gioia; Thomas E Merchant; Robert J Ogg; Victor Santana; Shengjie Wu
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

Review 8.  Primary intracranial germ-cell tumors in adults: a practical review.

Authors:  Jacoline E C Bromberg; Brigitta G Baumert; Filip de Vos; Johanna M M Gijtenbeek; Erkan Kurt; Anneke M Westermann; Pieter Wesseling
Journal:  J Neurooncol       Date:  2013-03-23       Impact factor: 4.130

9.  Slower processing speed after treatment for pediatric brain tumor and acute lymphoblastic leukemia.

Authors:  Lisa S Kahalley; Heather M Conklin; Vida L Tyc; Melissa M Hudson; Stephanie J Wilson; Shengjie Wu; Xiaoping Xiong; Pamela S Hinds
Journal:  Psychooncology       Date:  2013-02-28       Impact factor: 3.894

10.  Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia.

Authors:  Michelle Monje; Moriah E Thomason; Laura Rigolo; Yalin Wang; Deborah P Waber; Stephen E Sallan; Alexandra J Golby
Journal:  Pediatr Blood Cancer       Date:  2012-08-08       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.